Colin Dillon

Colin Dillon is a Lecturer in the Department of Science at Shannon Consortium University (SETU). His research focuses on innovative drug delivery systems, particularly transdermal technologies using microneedle formulations for peptide therapeutics. He holds a Doctoral Thesis from 2017 titled 'Development of Novel Transdermal Drug Delivery Technologies for Therapeutic Peptides.'

Education: PhD in Pharmaceutical Science (2017, Unpublished).

Research Interests: Specializes in transdermal delivery mechanisms involving povidone, trehalose, and polymyxin B, with emphasis on optimizing drug release profiles and stability in biomedical applications. Utilizes pig models for in vivo testing and polymer matrix characterization.

Collaborations: Works closely with co-authors like H. Hughes, N. J. O'Reilly, and P. McLoughlin on microneedle formulation and characterization projects. His work has been referenced in patents and cited over 100 times across Scopus and Mendeley.

Labs/Teams: Active in pharmaceutical formulation labs within the Department of Science, focusing on translational research for biomedical applications.